CRISM Therapeutics Corporation

CRISM Therapeutics Corporation develops a drug delivery technology intended to improve the clinical performance of cancer treatments for solid tumors by delivering chemotherapy drugs locally. Its lead product, ChemoSeed, can be implanted directly into a tumor or into the resection margin after tumor removal. The company also provides formulation and consultancy services. Formerly known as Amur Minerals Corporation, it changed its name to CRISM Therapeutics Corporation in May 2024 and is based in Road Town, the British Virgin Islands.